The U.S. Food and Drug Administration approved a new COVID vaccine shot Monday, as cooler temperatures — and accompanying flu and cold season — approach. The shots, manufactured by Pfizer-BioNTech and Moderna, correspond to an Omicron subvariant and are greenlit for people 6 months and older.

“We’ve been waiting for this,” said Dr. Brian Lamb, an internal medicine doctor with Allegheny Health Network. “We have a lot of patients that are going to benefit from having extra protection going into the fall.”

The Centers for Disease Control and Prevention is expected to meet Tuesday to discuss recommendations for the rollout of the booster, including who should receive it. After that meeting, CDC director Mandy Cohen is likely to give final approval, meaning that the shots will be available for shipping.

The FDA approved the shots for ages 12 and older, and granted emergency use authorization for ages 6 months to 11 years.

Advertise with us

Dr. Donald Yealy, UPMC’s chief medical director and senior vice president of its Health Services division, said last week that UPMC was planning to contact manufacturers on the same day that the federal approval came in, expecting to be able to distribute the vaccine within days or weeks.

COVID-19 cases have been on the rise locally and nationally this summer, though far from the peaks seen in previous years.

“Vaccination remains critical to public health and continued protection against serious consequences of COVID-19, including hospitalization and death,” Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, said in a news release.

Moderna's COVID vaccine production

Weekly emergency department visits for COVID began increasing the first week of July and hit a peak on Aug. 26, at 60,196 visits nationwide, with infants ages 0 to 1 years accounting for the majority of visits. New COVID-related admissions rose to more than 17,000 for the week of Aug. 26 — higher than earlier in the year but much lower than the 37,000 admissions the same time last year.

Pennsylvania is mirroring the national increase of visits with COVID illness, according to data from the CDC. Wastewater results from Allegheny County show a 9% daily increase in viral markers for the week of Aug. 22 to 30 but, without accurate surveillance due to at-home tests eclipsing PCR tests, it is difficult to get a true sense of the prevalence of community transmission.

Advertise with us

About 20.5% of adults in the U.S. received the bivalent COVID vaccine booster, according to the CDC. But in part because of the increase in COVID cases locally, Dr. Lamb has heard interest from patients — particularly those at high risk — in getting the updated vaccine.

“A lot are coming in asking when they can get it — a lot of them are used to the idea that we vaccinate in the fall,” he said. “A lot of people are catching it again, and I think people are realizing, it’s still here, we still need to protect ourselves.”

The FDA also acknowledged as part of its approval that an updated COVID vaccine could become a regular fall event, stating that the shots “may need to be updated annually, as is done for the seasonal influenza vaccine.”

This vaccine rollout is different than those for previous COVID vaccines because of the expiration of emergency declarations that allowed for faster processing. For previous versions of the vaccine, the Allegheny County Health Department had access to vials prior to federal approval to allow for speedy rollout of the shots.

Additionally, the cost of the vaccine will not be covered by the government; that is now left up to private insurance and assistance programs. Officials expect insurance to cover the cost of shots, and that the CDC’s Bridge Access Program will catch costs for the un- and underinsured. An estimated 25-30 million U.S. adults do not have health insurance, per the CDC.

Advertise with us

Vaccine manufacturers are also expected to donate some doses to the uninsured, said Dr. Lamb, who does not expect cost to be an issue.

While Dr. Lamb doesn’t believe that the vaccine is essential for patients who are not high risk, he certainly believes it’s worth a conversation with their doctors. The only patients he does not recommend receive it are those who had COVID within the past six weeks.

“We are fortunate that we have gotten to this point where it’s not as severe, but it’s important that people realize that it’s still there, people can still get sick, people can still die,” he said. “This is the one thing we can offer that can really protect them.”

Hanna Webster contributed to this article.

Anya Sostek: asostek@post-gazette.com